0

The full content of Annals is available to subscribers

Subscribe/Learn More  >
Editorials |

An Editorial Update: Should She Take Aspirin?

Cynthia Mulrow, MD, MSc, Deputy Editor; and Michael Pignone, MD, MPH
[+] Article and Author Information

From the American College of Physicians, Philadelphia, PA 19106-1572, and University of North Carolina at Chapel Hill, Chapel Hill, NC 27599.


Acknowledgments: The authors thank Russell Localio and Colin Baigent for their careful review and helpful comments during preparation of this editorial.

Potential Financial Conflicts of Interest: Honoraria/Grants received: M. Pignone (Bayer Pharmaceuticals).

Requests for Single Reprints: Customer Service, American College of Physicians, 190 N. Independence Mall West, Philadelphia, PA 19106-1572.

Current Author Addresses: Dr. Mulrow: American College of Physicians, 190 N. Independence Mall West, Philadelphia, PA 19106-1572.

Dr. Pignone: Division of General Internal Medicine, University of North Carolina at Chapel Hill, 5039 Old Clinic Building, UNC Hospital, Chapel Hill, NC 27599-7110.


Ann Intern Med. 2005;142(11):942-943. doi:10.7326/0003-4819-142-11-200506070-00015
Text Size: A A A

In 2002, we published a systematic review of aspirin for the primary prevention of cardiovascular disease for the U.S. Preventive Services Task Force (1). The review suggested the following: “For 1000 patients with a 5% risk for coronary heart disease events over 5 years, aspirin would prevent 6 to 20 myocardial infarctions but would cause 0 to 2 hemorrhagic strokes and 2 to 4 major gastrointestinal bleeding events.” Because few women participated in the trials summarized in the review, we could not reliably determine whether sex modifies the beneficial effects of aspirin. We looked forward to the publication of the Women's Health Study (WHS), a large, double-blind, randomized, placebo-controlled trial examining the effect of low-dose aspirin on cardiovascular events in women 45 years of age or older, expecting that it would clarify the benefits and risks of aspirin among women. The study was published in March 2005 (2). Here's our take on how it clarifies the use of aspirin to prevent cardiovascular disease in women.

Topics

aspirin ; women

First Page Preview

View Large
First page PDF preview

Figures

Tables

References

Letters

NOTE:
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s "Cited By" API will populate this tab (http://www.crossref.org/citedby.html).

Comments

Submit a Comment
Submit a Comment

Summary for Patients

Clinical Slide Sets

Terms of Use

The In the Clinic® slide sets are owned and copyrighted by the American College of Physicians (ACP). All text, graphics, trademarks, and other intellectual property incorporated into the slide sets remain the sole and exclusive property of the ACP. The slide sets may be used only by the person who downloads or purchases them and only for the purpose of presenting them during not-for-profit educational activities. Users may incorporate the entire slide set or selected individual slides into their own teaching presentations but may not alter the content of the slides in any way or remove the ACP copyright notice. Users may make print copies for use as hand-outs for the audience the user is personally addressing but may not otherwise reproduce or distribute the slides by any means or media, including but not limited to sending them as e-mail attachments, posting them on Internet or Intranet sites, publishing them in meeting proceedings, or making them available for sale or distribution in any unauthorized form, without the express written permission of the ACP. Unauthorized use of the In the Clinic slide sets will constitute copyright infringement.

Toolkit

Buy Now

to gain full access to the content and tools.

Want to Subscribe?

Learn more about subscription options

Advertisement
Related Articles
Related Point of Care
Topic Collections
PubMed Articles
Forgot your password?
Enter your username and email address. We'll send you a reminder to the email address on record.
(Required)
(Required)